Pompe Lactation Sub-Registry
A Sub-Registry to Determine the Presence of Alglucosidase Alfa in Breast Milk From Women With Pompe Disease Treated With Alglucosidase Alfa.
Sponsor: Genzyme, a Sanofi Company
A observational or N/A phase clinical study on Glycogen Storage Disease and Pompe Disease, this trial is completed. The trial is conducted by Genzyme, a Sanofi Company and has accumulated 13 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting
-
Feb 2023 — Mar 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
Sep 2022 — Feb 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2022 — Sep 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting
-
Jun 2018 — Jan 2021 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Feb 2017 — Jan 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Genzyme, a Sanofi Company
For direct contact, visit the study record on ClinicalTrials.gov .